Target intelligence / Profile preview

Protein unc-13 homolog B (UNC13B)

Target
UNC13B
Molecular classification
Other (Presynaptic active zone scaffold protein involved in exocytosis and vesicle priming), Diacylglycerol receptor, Synaptic vesicle priming factor, Protein coding gene
01

Overview

UNC13B, also known as Protein unc-13 homolog B (Munc13-2), is a multidomain presynaptic active zone protein required for synaptic vesicle priming and effective neurotransmitter release. Highly expressed in the brain, especially the cerebral cortex, and in other tissues including kidney and eye, UNC13B interacts with diacylglycerol and calmodulin, and contains multiple C2 domains and a DAG-binding C1 domain. Hyperglycemia can upregulate its expression and induce apoptosis in kidney cells. In the nervous system, UNC13B orchestrates the assembly and positioning of synaptic vesicles, controls the location and efficiency of vesicle release, and enables fast, reliable neurotransmission by facilitating the fusion of vesicles with the neuronal membrane. It is distinct from the closely related UNC13A, contributing uniquely to neural information processing, such as olfactory decoding, and its dysfunction or altered expression has been implicated in several neurologic and renal diseases.

Other names
UNC13BMunc13-2Protein unc-13 homolog BUncoordinated-13 homolog BHomolog of rat Munc13 (diacylglycerol-binding)Unc13h2UNC13Munc13Hmunc13Protein unc-13-likeUnc13-like
02

Biological functions

Synaptic vesicle priming and exocytosis (critical for neurotransmitter release at presynaptic terminals)Regulation of neuronal excitabilityActivity-dependent refilling of readily releasable vesicle pool (RRP)Vesicle maturationApoptosis mediation (in renal cells under hyperglycemia)Regulation of synaptic plasticity (especially hippocampal)
03

Disease associations

Neurodegenerative disease (e.g., links to epilepsy, schizophrenia, autism spectrum disorder, ALS, FTD)Renal complications in hyperglycemiaFamilial hemophagocytic lymphohistiocytosisOther (neurological and immunological disorders)
04

Safety considerations

Potential for aberrant apoptosis induction in kidney cells under hyperglycemic conditionsDysregulation may contribute to neurological disorders via impaired neurotransmitter releaseGenetic mutations could be implicated in familial hemophagocytic lymphohistiocytosis and neuropsychiatric phenotypes

Beyond the preview

Go deeper on Protein unc-13 homolog B (UNC13B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein unc-13 homolog B (UNC13B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call